<DOC>
	<DOCNO>NCT00868452</DOCNO>
	<brief_summary>This clinical study design test hypothesis lurasidone effective , tolerable , safe add treatment lithium Divalproex treatment patient bipolar I depression .</brief_summary>
	<brief_title>Lurasidone - A 6-week Study Patients With Bipolar I Depression ( Add-on )</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Subject diagnose bipolar I disorder , resent episode depress Subject must lifetime history least one bipolar manic mixed episode Subject must take lithium divalproex least 28 day prior screen History nonresponse adequate ( 6week ) trial three antidepressant ( without mood stabilizer ) current episode Subject hospitalize manic mixed episode within 60 day prior randomization Imminent risk suicide injury self , others , property</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Bipolar I</keyword>
	<keyword>Latuda</keyword>
	<keyword>Lurasidone</keyword>
</DOC>